Gyre Therapeutics's market cap is currently $1.09B. The company's EPS TTM is $-17.572; its P/E ratio is ―; Gyre Therapeutics is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 113.45M	$ 794.00K	$ 7.34M	$ 20.95M	$ 0.00
Gross Profit	$ 108.81M	$ -4.00K	$ -42.00K	$ 11.79M	$ -43.86M
Operating Income	$ -67.23M	$ -8.61M	$ -87.89M	$ -57.37M	$ -57.28M
EBITDA	$ 20.33M	$ 10.33M	$ -87.60M	$ -57.37M	$ -57.28M
Net Income	$ -92.93M	$ 2.30M	$ -87.93M	$ -55.54M	$ -52.89M
Balance Sheet
Cash & Short-Term Investments	$ 33.51M	$ 21.67M	$ 46.85M	$ 79.35M	$ 76.86M
Total Assets	$ 116.54M	$ 28.44M	$ 55.66M	$ 94.85M	$ 98.55M
Total Debt	$ 409.00K	$ 38.00K	$ 2.38M	$ 1.64M	$ 1.80M
Net Debt	$ -33.10M	$ -21.63M	$ -41.96M	$ -28.72M	$ -13.57M
Total Liabilities	$ 38.06M	$ 50.13M	$ 14.57M	$ 18.78M	$ 30.22M
Stockholders' Equity	$ -15.83M	$ -21.69M	$ 41.09M	$ 76.07M	$ 68.34M
Cash Flow
Free Cash Flow	$ 17.31M	$ -38.09M	$ -84.59M	$ -55.31M	$ -43.68M
Operating Cash Flow	$ 25.89M	$ -33.10M	$ -83.75M	$ -55.05M	$ -43.61M
Investing Cash Flow	$ -19.76M	$ 55.43M	$ 48.19M	$ 9.66M	$ 27.39M
Financing Cash Flow	$ 2.50M	$ -45.01M	$ 49.55M	$ 60.38M	$ 327.00K

Currency in USD

Gyre Therapeutics Earnings and Revenue History

Income Statement >

Gyre Therapeutics Debt to Assets

Balance Sheet >

Gyre Therapeutics Cash Flow

Cash Flow >

Gyre Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing